|
1
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Galluzzi L, Pietrocola F, Levine B and
Kroemer G: Metabolic control of autophagy. Cell. 159:1263–1276.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:651–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cicchini M, Chakrabarti R, Kongara S,
Price S, Nahar R, Lozy F, Zhong H, Vazquez A, Kang Y and Karantza
V: Autophagy regulator BECN1 suppresses mammary tumorigenesis
driven by WNT1 activation and following parity. Autophagy.
10:2036–2052. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang F, Kumano M, Beraldi E, Fazli L, Du
C, Moore S, Sorensen P, Zoubeidi A and Gleave ME: Clusterin
facilitates stress-induced lipidation of LC3 and autophagosome
biogenesis to enhance cancer cell survival. Nat Commun. 5:57752014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Zhang H, Sun M, Yin Z and Qian J:
High mobility group box 1-mediated autophagy promotes neuroblastoma
cell chemoresistance. Oncol Rep. 34:2969–2976. 2015.PubMed/NCBI
|
|
9
|
Chen S, Zhu X, Qiao H, Ye M, Lai X, Yu S,
Ding L, Wen A and Zhang J: Protective autophagy promotes the
resistance of HER2-positive breast cancer cells to lapatinib.
Tumour Biol. 37:2321–2331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giuliano S, Cormerais Y, Dufies M, Grépin
R, Colosetti P, Belaid A, Parola J, Martin A, Lacas-Gervais S,
Mazure NM, et al: Resistance to sunitinib in renal clear cell
carcinoma results from sequestration in lysosomes and inhibition of
the autophagic flux. Autophagy. 11:1891–1904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Crystal AS, Shaw AT, Sequist LV, Friboulet
L, Niederst MJ, Lockerman EL, Frias RL, Gainor JF, Amzallag A,
Greninger P, et al: Patient-derived models of acquired resistance
can identify effective drug combinations for cancer. Science.
346:1480–1486. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z, Wang N, Li W, Liu P, Chen Q, Situ
H, Zhong S, Guo L, Lin Y, Shen J and Chen J: Caveolin-1 mediates
chemoresistance in breast cancer stem cells via β-catenin/ABCG2
signaling pathway. Carcinogenesis. 35:2346–2356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi Y, Tan SH, Ng S, Zhou J, Yang ND, Koo
GB, McMahon KA, Parton RG, Hill MM, Del Pozo MA, et al: Critical
role of CAV1/caveolin-1 in cell stress responses in human breast
cancer cells via modulation of lysosomal function and autophagy.
Autophagy. 11:769–784. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shiroto T, Romero N, Sugiyama T,
Sartoretto JL, Kalwa H, Yan Z, Shimokawa H and Michel T: Caveolin-1
is a critical determinant of autophagy, metabolic switching, and
oxidative stress in vascular endothelium. PLoS One. 9:e878712014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu KN, Queenan M, Brody JR, Potoczek M,
Sotgia F, Lisanti MP and Witkiewicz AK: Loss of stromal caveolin-1
expression in malignant melanoma metastases predicts poor survival.
Cell Cycle. 10:4250–4255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao Z, Han FH, Yang SB, Hua LX, Wu JH and
Zhan WH: Loss of stromal caveolin-1 expression in colorectal cancer
predicts poor survival. World J Gastroenterol. 21:1140–1147. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pu J, Schindler C, Jia R, Jarnik M,
Backlund P and Bonifacino JS: BORC, a multisubunit complex that
regulates lysosome positioning. Dev Cell. 33:176–188. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun NK, Huang SL, Lu HP, Chang TC and Chao
CC: Integrative transcriptomics-based identification of cryptic
drivers of taxol-resistance genes in ovarian carcinoma cells:
Analysis of the androgen receptor. Oncotarget. 6:27065–27082. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei Y, Pattingre S, Sinha S, Bassik M and
Levine B: JNK1-mediated phosphorylation of Bcl-2 regulates
starvation-induced autophagy. Mol Cell. 30:678–688. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Dang TA, Shen J, Hicks J,
Chintagumpala M, Lau CC and Man TK: Plasma proteome predicts
chemotherapy response in osteosarcoma patients. Oncol Rep.
25:303–314. 2011.PubMed/NCBI
|
|
23
|
Shibutani ST, Saitoh T, Nowag H, Münz C
and Yoshimori T: Autophagy and autophagy-related proteins in the
immune system. Nat Immunol. 16:1014–1024. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bao XH, Naomoto Y, Hao HF, Watanabe N,
Sakurama K, Noma K, Motoki T, Tomono Y, Fukazawa T, Shirakawa Y, et
al: Autophagy: Can it become a potential therapeutic target? Int J
Mol Med. 25:493–503. 2010.PubMed/NCBI
|
|
25
|
Axe EL, Walker SA, Manifava M, Chandra P,
Roderick HL, Habermann A, Griffiths G and Ktistakis NT:
Autophagosome formation from membrane compartments enriched in
phosphatidylinositol 3-phosphate and dynamically connected to the
endoplasmic reticulum. J Cell Biol. 182:685–701. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levine B: Cell biology: Autophagy and
cancer. Nature. 446:745–747. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Williams TM and Lisanti MP: Caveolin-1 in
oncogenic transformation, cancer, and metastasis. Am J Physiol Cell
Physiol. 288:C494–C506. 2005. View Article : Google Scholar : PubMed/NCBI
|
